Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

Iohexol 200mg Iodine/Ml Injectable 120 Ml 300 Ml 50 Ml 600 Ml 72 Ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1548-2012
Class II · Moderate risk

Insulin

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1547-2012
Class II · Moderate risk

1.5% Glycine Irrigation

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7974-08 D-618-2013
Class II · Moderate risk

20% Dextrose Injection

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7935-19 D-616-2013
Class II · Moderate risk

5% Dextrose Injection USP

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7922-02 D-614-2013
Class II · Moderate risk

70% Dextrose Injection USP

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7120-07 D-612-2013
Class II · Moderate risk

ChloraPrep One-Step

Lack of Assurance of Sterility: Firm mistakenly released quarantined, non conforming material that failed sterility testing.

Terminated Sterility / contamination Carefusion 213, Llc NDC 54365-400-01 D-004-2013
Class II · Moderate risk

Multihance Multipack

Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.

Terminated Sterility / contamination Bracco Diagnostics Inc D-1665-2012
Class II · Moderate risk

ChloraPrep with Tint

Lack of Assurance of Sterility: A customer complaint reported some units had incomplete seals (open seals) on the Individual unit packaging.

Terminated Sterility / contamination Carefusion 213, Llc D-1674-2012
Class II · Moderate risk

Murocel (methylcellulose)

Lack of Assurance of Sterility: Bausch & Lomb, Inc. is recalling 7 Lots of Murocel Methylcellulose Lubricant Opthalmic Solution 1% (15 mL). Product was found to be OOS for Antimicrobial Effectiveness testing (AET) at the 12 month stability time point.

Terminated Sterility / contamination Bausch & Lomb, Inc. NDC 24208-280-15 D-1370-2012